Do Stem Cell Treatments Really Work for Arthritis? What the Evidence Shows

By Dr. Jeffrey Peng, MD · Published March 4, 2026 · 8 min read

Watch the Full Video

Stem cell therapy has become one of the most talked-about treatments in the world of joint pain and arthritis. The promise is alluring: a single injection that could repair damaged cartilage, eliminate chronic pain, and restore mobility without surgery. But does the science actually support the hype? As a sports medicine physician who specializes in orthobiologic treatments, I want to walk you through what the latest clinical evidence tells us about stem cell injections for osteoarthritis — and what I recommend instead.

What Are the Three Types of Stem Cell Treatments for Arthritis?

There are three main types of stem cell preparations currently used for osteoarthritis. The first is Bone Marrow Aspirate Concentrate (BMAC), which is harvested from the patient's pelvic bone. The second is Adipose Stromal Vascular Fraction (SVF), which is derived from fat tissue through liposuction. The third is umbilical cord-derived mesenchymal stromal cells, which are ethically sourced from donated tissue and processed for clinical use.

All three approaches share a common goal: they attempt to deliver mesenchymal stem cells and growth factors into the joint to promote tissue repair, reduce inflammation, and regenerate damaged cartilage and connective tissue. In theory, this sounds like a breakthrough. In practice, the results tell a very different story.

Does Stem Cell Therapy Actually Work for Knee Osteoarthritis?

While smaller studies and case reports have occasionally shown promising results, the overall body of evidence for stem cell therapy in osteoarthritis remains inconclusive. That is precisely why experts in the orthobiologic space were eagerly awaiting the results of a landmark clinical trial published in Nature Medicine — one of the largest and most rigorous studies to date.

This phase 2/3 randomized controlled trial enrolled nearly 500 patients with knee osteoarthritis and compared all three types of stem cell injections (BMAC, SVF, and umbilical cord tissue) against standard cortisone injections. The results at one year were striking: none of the stem cell treatments outperformed cortisone injections in pain relief. Furthermore, no treatment group showed meaningful improvement on MRI scoring, suggesting that none of the cellular therapies promoted measurable cartilage repair or tissue regeneration within the joint.

Why This Study Changes the Conversation About Stem Cells

There are several reasons this trial carries more weight than previous research. First, the sample size of nearly 500 patients is significantly larger than the 20 to 30 patients typically enrolled in earlier stem cell studies, giving the findings considerably greater statistical reliability. Second, the study was a multicenter, randomized, single-blind controlled trial — the gold standard for evaluating treatment effectiveness.

Perhaps the most important takeaway is the cost-effectiveness question: is it worth paying thousands of dollars for a stem cell procedure when it performs no better than a cortisone injection that costs a fraction of the price? Some advocates argue that a one-year follow-up may not capture long-term structural benefits. However, most patients seeking stem cell therapy are looking for meaningful relief in the near term, and paying a premium for a treatment that may take years to show any theoretical advantage is a difficult proposition to justify.

Should You Get Stem Cell Injections for Arthritis?

Based on the current evidence, I do not recommend stem cell treatments for the management of osteoarthritis. This position is informed by the mixed and largely disappointing results from recent clinical trials, which consistently show little to no benefit over less expensive alternatives. The high cost of stem cell procedures — often several thousand dollars per treatment — represents a substantial financial risk when the clinical evidence does not support a clear advantage.

It is also worth noting that while cortisone injections matched the performance of stem cells in the trial described above, cortisone is not without its own risks. I have covered the potential downsides of corticosteroid injections in detail elsewhere, and I generally advise against routine cortisone use as well. So what is the better option?

Why Platelet Rich Plasma Is a Better Alternative to Stem Cells

For patients exploring nonsurgical, biologic treatment options for knee osteoarthritis, I recommend platelet rich plasma (PRP) injections. PRP has a substantially stronger evidence base and is considerably more affordable than stem cell procedures.

A large, multicenter, sham-controlled randomized clinical trial involving over 600 patients demonstrated that PRP injections produced significantly better pain relief and functional improvement compared to placebo saline injections, with benefits sustained for at least 24 months. A systematic review and meta-analysis further confirmed that PRP outperforms cortisone injections at three, six, and nine months post-treatment. A separate systematic review also showed that PRP is superior to hyaluronic acid alone for knee osteoarthritis.

Additional studies have shown that PRP injections produce outcomes comparable to arthroscopic surgery for knee osteoarthritis. Perhaps most compellingly, a retrospective survival analysis of over 1,000 patients found that PRP injections delayed the need for total knee replacement, with over 85 percent of patients avoiding surgery during a five-year follow-up period.

The effectiveness of PRP has also been recognized by major medical societies. Both the American Academy of Orthopaedic Surgeons and the American Medical Society for Sports Medicine have published summaries and consensus statements acknowledging PRP's significant benefits in reducing pain and improving joint function for knee osteoarthritis.

Not All PRP Injections Are the Same

One critical point that often gets overlooked is that the quality and composition of PRP can vary significantly depending on the preparation method, platelet concentration, and injection protocol. In my practice, I take great care to optimize every aspect of the PRP preparation process because these factors directly influence clinical outcomes. If you are considering PRP therapy, it is important to work with a provider who understands these variables and can tailor the treatment to your specific condition.

If you would like to learn more about whether PRP is right for you, I encourage you to schedule a consultation to discuss your options.

---

References

1. Mautner K, Gottschalk M, Boden SD, et al. Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial. Nat Med. 2023;29(12):3120-3126. doi:10.1038/s41591-023-02632-w

2. Chu J, Duan W, Yu Z, et al. Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2022;30(12):4063-4071. doi:10.1007/s00167-022-06887-7

3. McLarnon M, Heron N. Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis. BMC Musculoskelet Disord. 2021;22(1):550. doi:10.1186/s12891-021-04308-3

4. Baria MR, Vasileff WK, Borchers J, et al. Treating knee osteoarthritis with platelet-rich plasma and hyaluronic acid combination therapy: a systematic review. Am J Sports Med. 2022;50(1):273-281. doi:10.1177/0363546521998010

5. Singh N, Trivedi V, Kumar V, et al. A comparative study of osteoarthritis knee arthroscopy versus intra-articular platelet rich plasma injection: a randomised study. Malays Orthop J. 2022;16(2):31-40. doi:10.5704/MOJ.2207.004

6. Sánchez M, Jorquera C, Sánchez P, et al. Platelet-rich plasma injections delay the need for knee arthroplasty: a retrospective study and survival analysis. Int Orthop. 2021;45(2):401-410. doi:10.1007/s00264-020-04669-9

7. American Academy of Orthopaedic Surgeons. Technology overview: PRP for knee OA. AAOS.org.

8. American Medical Society for Sports Medicine. Consensus statement on PRP for musculoskeletal conditions. Clin J Sport Med. 2021;31(6). Full text.

---

Medical Disclaimer: This content is for educational purposes only and does not substitute for the medical advice of a physician. Always consult your healthcare provider before beginning any new treatment program. The information presented reflects the opinion of Dr. Jeffrey Peng and does not represent the views of his employers or affiliated hospital systems.